UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 96

Sortiert nach

A randomized, placebo-controlled trial of late Na current inhibition (ranolazine) in coronary microvascular dysfunction (CMD): impact on angina and myocardial perfusion reserve

European heart journal, 2016-05, Vol.37 (19), p.1504-1513

2016

Volltextzugriff (PDF)

The Potential for Postrandomization Confounding in Randomized Clinical Trials

JAMA : the journal of the American Medical Association, 2016-06, Vol.315 (21), p.2273

2016

Volltextzugriff (PDF)

Contraceptive Hormone Use and Cardiovascular Disease

Journal of the American College of Cardiology, 2009-01, Vol.53 (3), p.221-231

2009

Volltextzugriff (PDF)

Age at Menarche and Risk of Cardiovascular Disease Outcomes: Findings From the National Heart Lung and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation

Journal of the American Heart Association, 2019-06, Vol.8 (12), p.e012406-e012406

2019

Volltextzugriff (PDF)

Clinical Practice Variations in the Management of Ischemia With No Obstructive Coronary Artery Disease

Journal of the American Heart Association, 2022-10, Vol.11 (19), p.e022573-e022573

2022

Volltextzugriff (PDF)

Menopausal Hormone Therapy and Cardiovascular Disease: The Role of Formulation, Dose, and Route of Delivery

The journal of clinical endocrinology and metabolism, 2021-05, Vol.106 (5), p.1245-1254

2021

Volltextzugriff (PDF)

Statin therapy in midlife women

Menopause (New York, N.Y.), 2021-09, Vol.28 (9), p.1067

Shufelt, Chrisandra L

2021

Volltextzugriff (PDF)

Gender, Cardiovascular Disease, and the Sexism of Obesity

Journal of the American College of Cardiology, 2015-11, Vol.66 (18), p.1958-1960

2015

Volltextzugriff (PDF)

Hypothalamic Amenorrhea and the Long-Term Health Consequences

Seminars in reproductive medicine, 2017-05, Vol.35 (3), p.256

2017

Volltextzugriff (PDF)

Hormone therapy in menopause: An update on cardiovascular disease considerations

Trends in cardiovascular medicine, 2015-08, Vol.25 (6), p.540-549

2015

Volltextzugriff (PDF)

Internal medicine resident education improves cardiac rehabilitation knowledge, attitudes, and referral rates: A pilot study

American journal of preventive cardiology, 2022-06, Vol.10, p.100349-100349, Article 100349

2022

Volltextzugriff (PDF)

Case report: Repeat coronary function testing in women with ischemia and no obstructive coronary artery disease

Frontiers in cardiovascular medicine, 2023-07, Vol.10, p.1096265

2023

Volltextzugriff (PDF)

Pregnancy and Reproductive Risk Factors for Cardiovascular Disease in Women

Circulation research, 2022-02, Vol.130 (4), p.652-672

2022

Volltextzugriff (PDF)

Biometric and Psychometric Remote Monitoring and Cardiovascular Risk Biomarkers in Ischemic Heart Disease

Journal of the American Heart Association, 2020-09, Vol.9 (18), p.e016023

2020

Volltextzugriff (PDF)

Why is everyone talking about menopause?

Maturitas, 2023-11, Vol.177, p.107777-107777, Article 107777

2023

Volltextzugriff (PDF)

Dyslipidemia in midlife women: Approach and considerations during the menopausal transition

Maturitas, 2022-12, Vol.166, p.14-20

2022

Volltextzugriff (PDF)

The relation between excess adiposity and breast cancer in women: Clinical implications and management

Critical reviews in oncology/hematology, 2024-01, Vol.193, p.104213-104213, Article 104213

2024

Volltextzugriff (PDF)

Sex-Specific Physiology and Cardiovascular Disease

Sex-Specific Analysis of Cardiovascular Function, 2018, Vol.1065, p.433-454

2018

Volltextzugriff (PDF)

Autoimmune rheumatic diseases in women with coronary microvascular dysfunction: a report from the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction (WISE-CVD) project

Frontiers in cardiovascular medicine, 2023-05, Vol.10, p.1155914-1155914

2023

Volltextzugriff (PDF)

Association of Migraine and Vasomotor Symptoms

Mayo Clinic proceedings, 2023-05, Vol.98 (5), p.701-712

2023

Volltextzugriff (PDF)

Impact of Menopause Symptoms on Women in the Workplace

Mayo Clinic proceedings, 2023-06, Vol.98 (6), p.833-845

2023

Volltextzugriff (PDF)

Menopause transition and cardiovascular disease risk

Maturitas, 2024-07, Vol.185, p.107974, Article 107974

2024

Volltextzugriff (PDF)

Risk factors for heart failure in women with ischemia and no obstructive coronary artery disease

American heart journal plus, 2021-08, Vol.8, p.100035-100035, Article 100035

2021

Volltextzugriff (PDF)

Menopause in the workplace: Challenges, impact, and next steps

Maturitas, 2024-07, Vol.185, p.107983, Article 107983

2024

Volltextzugriff (PDF)

Weight loss response to semaglutide in postmenopausal women with and without hormone therapy use

Menopause (New York, N.Y.), 2024-04, Vol.31 (4), p.266

2024

Volltextzugriff (PDF)

1 – 25 von 96

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(86)
Mit Volltextzugriff
(68)

Publikationsform

Sprache

Englisch
(96)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(72)
Science & Technology
(72)
Humans
(55)
Female
(52)
Cardiac & Cardiovascular Systems
(29)
Cardiovascular System & Cardiology
(29)
Middle Aged
(28)
Obstetrics & Gynecology
(28)
Menopause
(22)
Risk Factors
(19)
Adult
(16)
Aged
(16)
Cardiovascular Disease
(12)
Male
(11)
Women
(10)
Cardiovascular Diseases
(9)
Cardiovascular Diseases - Epidemiology
(9)
Coronary Microvascular Dysfunction
(9)
Cardiovascular
(8)
Coronary Angiography
(7)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

A randomized, placebo-controlled trial of late Na current inhibition (ranolazine) in coronary microvascular dysfunction (CMD): impact on angina and myocardial perfusion reserve

The Potential for Postrandomization Confounding in Randomized Clinical Trials

Contraceptive Hormone Use and Cardiovascular Disease

Age at Menarche and Risk of Cardiovascular Disease Outcomes: Findings From the National Heart Lung and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation

Clinical Practice Variations in the Management of Ischemia With No Obstructive Coronary Artery Disease

Menopausal Hormone Therapy and Cardiovascular Disease: The Role of Formulation, Dose, and Route of Delivery

Statin therapy in midlife women

Gender, Cardiovascular Disease, and the Sexism of Obesity

Hypothalamic Amenorrhea and the Long-Term Health Consequences

Hormone therapy in menopause: An update on cardiovascular disease considerations

Internal medicine resident education improves cardiac rehabilitation knowledge, attitudes, and referral rates: A pilot study

Case report: Repeat coronary function testing in women with ischemia and no obstructive coronary artery disease

Pregnancy and Reproductive Risk Factors for Cardiovascular Disease in Women

Biometric and Psychometric Remote Monitoring and Cardiovascular Risk Biomarkers in Ischemic Heart Disease

Why is everyone talking about menopause?

Dyslipidemia in midlife women: Approach and considerations during the menopausal transition

The relation between excess adiposity and breast cancer in women: Clinical implications and management

Sex-Specific Physiology and Cardiovascular Disease

Autoimmune rheumatic diseases in women with coronary microvascular dysfunction: a report from the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction (WISE-CVD) project

Association of Migraine and Vasomotor Symptoms

Impact of Menopause Symptoms on Women in the Workplace

Menopause transition and cardiovascular disease risk

Risk factors for heart failure in women with ischemia and no obstructive coronary artery disease

Menopause in the workplace: Challenges, impact, and next steps

Weight loss response to semaglutide in postmenopausal women with and without hormone therapy use

Suchergebnisse filtern